Hospital
Indiana University Health North Hospital INC
Indiana University Health North Hospital INC was paid $6.87M by Medicaid between Jan 2018 and Nov 2024, across 68 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 27% of everything it billed.
33Billing provider infoINDIANA UNIVERSITY HEALTH NORTH HOSPITAL INC
CARMEL, IN 46032
CARMEL, IN 46032
33aNPI1568492916assigned 07/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.87M
24GClaims55,367
24DCodes billed68
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#40 of 69
Median peer was paid$9.76M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,117 | $321K | |
| 2019 | 4,093 | $424K | |
| 2020 | 3,659 | $242K | |
| 2021 | 8,849 | $634K | |
| 2022 | 12,490 | $1.23M | |
| 2023 | 11,697 | $1.90M | |
| 2024incomplete | 5,462 | $2.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 27% | 938 | 882 | $1.86M |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 17% | 274 | 271 | $1.15M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.0% | 3,790 | 3,438 | $616K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.2% | 4,496 | 3,737 | $562K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.0% | 3,709 | 3,201 | $483K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 6.8% | 211 | 193 | $464K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 3.2% | 73 | 69 | $222K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 3,982 | 3,328 | $190K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2.6% | 940 | 829 | $180K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.2% | 847 | 717 | $150K |
| 99218 | 2.1% | 233 | 144 | $144K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 1,840 | 1,625 | $144K |
56 more codes
| 99221 | 1.7% | 177 | $113K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.3% | 796 | $92K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 2,611 | $84K |
| 71045 | Radiologic examination, chest; single view | <1% | 436 | $59K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 214 | $42K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 457 | $38K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,635 | $31K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 75 | $29K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 358 | $28K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 640 | $26K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $21K |
| 80053 | Comprehensive metabolic panel | <1% | 3,440 | $21K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,091 | $17K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 25 | $14K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,301 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,320 | $10K |
| 84484 | <1% | 1,355 | $8K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 63 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 198 | $7K |
| 87503 | <1% | 259 | $6K | |
| 76770 | <1% | 25 | $6K | |
| 81025 | <1% | 589 | $3K | |
| 85027 | <1% | 758 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 58 | $2K |
| 83690 | <1% | 675 | $2K | |
| 81003 | <1% | 1,203 | $2K | |
| 81001 | <1% | 944 | $2K | |
| 87276 | <1% | 202 | $1K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 15 | $1K |
| 87275 | <1% | 202 | $1K | |
| 76820 | <1% | 16 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 125 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 142 | $1K |
| 96415 | <1% | 13 | $1K | |
| 83970 | <1% | 25 | $908.16 | |
| 83880 | <1% | 30 | $844.10 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 18 | $718.21 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 13 | $602.38 |
| 83735 | <1% | 112 | $403.34 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $325.60 |
| 82728 | <1% | 25 | $299.86 | |
| 84425 | <1% | 15 | $297.22 | |
| 85379 | <1% | 32 | $226.76 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 48 | $209.51 |
| 84134 | <1% | 15 | $204.26 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $184.80 |
| 82607 | <1% | 13 | $165.88 | |
| 82746 | <1% | 13 | $161.70 | |
| 84590 | <1% | 14 | $150.93 | |
| 80061 | Lipid panel | <1% | 12 | $147.29 |
| 86003 | <1% | 108 | $130.50 | |
| 83540 | <1% | 13 | $71.17 | |
| 80076 | <1% | 13 | $60.18 | |
| 83605 | <1% | 14 | $23.74 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 22 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPUCKETT, KENNETHI (PRESIDENT)